[

regeneron

]
Both Elil Lilly and Regeneron have received US emergency use authorizations for their therapies.(AP | Representational image)

Eli Lilly, Regeneron Covid-19 antibodies study data shows promising results

AFP
PUBLISHED ON JAN 26, 2021 10:19 PM IST
Giving people ready-made antibodies can help those who are at high risk of severe disease because of weak immunity or underlying conditions.
Close
Regeneron said on Saturday it expects to have treatment doses of its drug ready for approximately 80,000 patients by the end of this month.(Reuters)
Regeneron said on Saturday it expects to have treatment doses of its drug ready for approximately 80,000 patients by the end of this month.(Reuters)

Regeneron Covid-19 drug to roll out in 30,000-dose shipment

By Bloomberg | Posted by Shivani Kumar
UPDATED ON NOV 24, 2020 04:21 AM IST
The drug, called REGN-COV2, received clearance from the US Food and Drug Administration for treatment of mild to moderate Covid-19 in adults and some children of at least 12 years of age.
Close
Trial findings released by Regeneron in October showed the drug may help treat patients outside the hospital, reducing virus levels and the need for further medical care.(REUTERS)
Trial findings released by Regeneron in October showed the drug may help treat patients outside the hospital, reducing virus levels and the need for further medical care.(REUTERS)

Regeneron gets emergency US clearance for Covid-19 therapy

By Bloomberg | Posted by Prashasti Singh
UPDATED ON NOV 22, 2020 07:34 AM IST
The treatment, administered to President Donald Trump after he contracted the coronavirus in October, consists of two monoclonal antibodies that target the spike protein used by the virus to enter cells. Trump was treated with the drug based on a compassionate-use request by his doctors.
Close
The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York.(Reuters File Photo)
The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York.(Reuters File Photo)

Regeneron’s antibody cocktail may offer protection against Covid-19: Study

By Press Trust of India | Posted by Kanishka Sarkar | New York
UPDATED ON OCT 10, 2020 02:18 PM IST
In the current study, published in the journal Science, the researchers tested REGN-COV2 in rhesus macaques, which manifest mild Covid-19 symptoms, and in golden hamsters, which show symptoms that are much more severe, including rapid weight loss.
Close
Patients of Covid-19 from across the country have asked to join clinical trials of the antibody-based Regeneron.(Reuters image)
Patients of Covid-19 from across the country have asked to join clinical trials of the antibody-based Regeneron.(Reuters image)

Regeneron’s Covid-19 treatment that Trump claims cured him: All you need to know

By hindustantimes.com | Edited by Prashasti Singh | Hindustan Times, New Delhi
UPDATED ON OCT 09, 2020 08:30 AM IST
Donald Trump’s physician said the President’s blood samples from Monday show that he had protective antibodies, but according to the pharmaceutical company, those were likely the Regeneron antibodies.
Close
A health worker collects a swab sample from a passenger to test for Covid-19 infection, Nizamuddin Railway Station, New Delhi, October 5, 2020.(Raj K Raj/HT PHOTO)
A health worker collects a swab sample from a passenger to test for Covid-19 infection, Nizamuddin Railway Station, New Delhi, October 5, 2020.(Raj K Raj/HT PHOTO)

Alternative medical tools against Covid-19

By Dr Narinder Kumar Mehra
UPDATED ON OCT 07, 2020 08:12 AM IST
The Covid-19 era has witnessed unprecedented scientific collaboration. Several welcome possibilities have emerged and these have the potential to protect the highest-risk health care workers, while also lessening the severity of Covid-19 in hospitalised patients until the vaccine becomes available.
Close
Trial results for the first 275 patients showed the greatest effect in those who had not yet mounted their own immune response prior to treatment.(Bloomberg)
Trial results for the first 275 patients showed the greatest effect in those who had not yet mounted their own immune response prior to treatment.(Bloomberg)

Regeneron says its Covid-19 treatment reduces viral levels, improves symptoms

By Reuters| Posted by Susmita Pakrasi | Reuters
PUBLISHED ON SEP 30, 2020 05:23 AM IST
REGN-COV2 is part of a class of biotech therapies known as monoclonal antibodies. Several companies are using the technology to manufacture copies of human antibodies to the new coronavirus.
Close
A separate Sanofi-led trial of Kevzara outside of the United States in hospitalized patients with severe and critical Covid-19 using a different dosing regimen is ongoing, the companies said.(REUTERS)
A separate Sanofi-led trial of Kevzara outside of the United States in hospitalized patients with severe and critical Covid-19 using a different dosing regimen is ongoing, the companies said.(REUTERS)

Regeneron, Sanofi arthritis drug fails Covid-19 study

By Reuters | Reuters
PUBLISHED ON JUL 03, 2020 07:51 AM IST
Other drugs in the same class, including Roche Holding AG’s Actemra, are also being studied as treatments for Covid-19.
Close
SHARE
Story Saved